Core Viewpoint - Kyverna Therapeutics, Inc. (KYTX) is facing a class action lawsuit, which has been notified to its shareholders by Levi & Korsinsky, indicating potential legal challenges for the company [1] Group 1 - The class action lawsuit is related to allegations against Kyverna Therapeutics, which may impact the company's reputation and financial standing [1] - Shareholders are urged to be aware of an upcoming deadline concerning the lawsuit, emphasizing the importance of timely action [1] - The notification serves as a reminder for investors to stay informed about legal proceedings that could affect their investments in Kyverna Therapeutics [1]

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics ...

KYTX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Kyverna Therapeutics, Inc. to Contact the Firm Today! ...

Levi & Korsinsky Notifies Kyverna Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - KYTX ...

NEW YORK, Jan. 17, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Kyverna Therapeutics, Inc. (NASDAQ: KYTX) pursuant and/or traceable to Kyverna’s initial public offering conducted on February 8, 2024 (the “IPO”), of the important February 7, 2025 lead plaintiff deadline. SO WHAT: If you purchased Kyverna common stock you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrang ...

Group 1 - The article announces a deadline for joining a class action lawsuit against Kyverna Therapeutics, Inc. (KYTX) [1] - The deadline to join the class action is set for February 7, 2025 [1] - The lawsuit pertains to potential grievances related to Kyverna Therapeutics, Inc. [1]

Kyverna Therapeutics, Inc. Is Being Sued For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm ...

Group 1 - The article discusses a class action lawsuit involving Kyverna Therapeutics, Inc. and highlights the opportunity for shareholders to take action [1] - The law firm Bronstein, Gewirtz and Grossman, LLC is mentioned as the contact for shareholders interested in participating in the lawsuit [1] - The focus is on the potential implications for shareholders and the legal proceedings surrounding the company [1]

Group 1 - The article discusses a pending class action lawsuit against Kyverna Therapeutics, Inc. (KYTX) for shareholders who have incurred losses [1] - Shareholders are encouraged to contact the law firm Levi & Korsinsky regarding their potential claims [1] - The focus is on the financial impact on shareholders and the legal recourse available to them [1]

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Kyverna Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - KYTX ...